by Karin Fleming | Apr 8, 2020
Not-for-profit Sutter Health Launches Clinical Trials with Gilead Sciences Sutter Health, together with health systems across Northern California has teamed up with Foster City-based Gilead Sciences on clinical trials for a promising treatment for COVID-19. The...
by Karin Fleming | Feb 18, 2020
SACRAMENTO, Calif. – Cancer researchers worldwide seek new clues to aid early detection and better treatments for cancer. The future is now, however, as research to support the development of a blood test for the detection of multiple types of the disease is underway...
by Karin Fleming | Apr 9, 2019
SAN FRANCISCO – Until now, research on aging and how to preserve independence as we age has come almost entirely from mice, worms, and flies, or human studies of blood specimens. Researchers at Sutter Health’s San Francisco Coordinating Center (SFCC) are...
by Karin Fleming | Feb 20, 2019
SAN FRANCISCO – Several Sutter Health sites participated in STRIVE, a study that is evaluating a new blood test for the early detection of multiple cancer types. Begun in 2017 and now closed to enrollment, the study recruited the highest number of Sutter...
by Karin Fleming | Feb 11, 2019
SAN FRANCISCO – Sutter Health is enrolling patients to the Targeted Agent and Profiling Utilization (TAPUR™) study, a national, prospective, non-randomized clinical trial determining the safety and efficacy of approved, targeted anticancer drugs. “The TAPUR Study...
